Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study

Cancer Medicine

Volumn 6, Issue 12, 2017, Pages 2822-2831

  Zhang, Lu Lu ^a   Zhou, Guan Qun ^a   Li, Yi Yang ^b   Tang, Ling Long ^a   Mao, Yan Ping ^a   Lin, Ai Hua ^c   Ma, Jun ^a   Qi, Zhen Yu ^a   Sun, Ying ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anemia; cervical node necrosis; nasopharyngeal carcinoma; survival

Indexed keywords

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CERVICAL NODE NECROSIS; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT PLANNING; AGED; BLOOD; CARCINOMA; CHI SQUARE DISTRIBUTION; COMPLICATION; DISEASE EXACERBATION; KAPLAN MEIER METHOD; LYMPH NODE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NASOPHARYNX TUMOR; NECROSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RADIATION TOLERANCE; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANEMIA; CARCINOMA; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIATION TOLERANCE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85031414620     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.1233     Document Type: Article

References (31)

1. Jemal, A., F. Bray, M. M. Center, J. Ferlay, E. Ward, D. Forman, et al. 2011. Global cancer statistics. CA Cancer J. Clin. 61:69–90.
2. Chan, A. T. 2010. Nasopharyngeal carcinoma. Annals Oncol. 21 Suppl 7:vii308–vii312.
3. Lee, A. W., J. C. Lin, and W. T. Ng. 2012. Current management of nasopharyngeal cancer. Semin. Radiat. Oncol. 22:233–244.
4. Xu, L., J. Pan, J. Wu, C. Pan, Y. Zhang, S. Lin, et al. 2010. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Radiother. Oncol. 96:94–99.
5. Sun, X., S. Su, C. Chen, F. Han, C. Zhao, W. Xiao, et al. 2014. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother. Oncol. 110:398–40.
6. Mao, Yan-Ping, Ling-Long Tang, Lei Chen, Ying Sun, Zhen-Yu Qi, Guan-Qun Zhou, et al. 2016. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. Chin. J. Cancer 35:103.
7. Liang, Wenhua, Guanzhu Shen, Yaxiong Zhang, Gang Chen, Wu Xuan, Yang Li, et al. 2016. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment. Chin. J. Cancer 35:98.
8. Harrison, L., and K. Blackwell. 2004. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?. Oncologist 9 Suppl 5:31–40.
9. Overgaard, J. 2007. Hypoxic radiosensitization: adored and ignored. J. Clin. Oncol. 25:4066–4074.
10. Cosse, J. P., and C. Michiels. 2008. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med. Chem. 8:790–797
11. Gao, J., J. Y. Hu, Y. F. Xia, W. Yi, Y. L. Tao, and G. Li. 2010. Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy. Chin. J. Cancer 29:561–566.
12. Guo, S. S., L. Q. Tang, Q. Y. Chen, L. Zhang, L. T. Liu, and P. Y. Huang. 2015. Is hemoglobin level in patients with nasopharyngeal carcinoma still a significant prognostic factor in the era of intensity modulated radiotherapy technology. PLoS ONE 10:e0136033.
13. Zhang, L. N., J. Tang, X. W. Lan, P. Y. OuYang, and F. Y. Xie. 2016. Pretreatment anemia and survival in nasopharyngeal carcinoma. Tumour Biol. 37:2225–2231.
14. Gao, J., Y. L. Tao, G. Li, W. Yi, and Y. F. Xia. 2012. Involvement of difference in decrease of hemoglobin level in poor prognosis of stage I and stage II nasopharyngeal carcinoma: implication in outcome of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 82:1471–1478.
15. Chua, D. T., J. S. Sham, and D. T. Choy. 2004. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone. Cancer 101:307–316.
16. Lan, M., Y. Huang, C. Y. Chen, F. Han, S. X. Wu, L. Tian, et al. 2015. Prognostic value of cervical nodal necrosis in nasopharyngeal carcinoma: analysis if 1800 patients with positive cervical nodal metastasis at MR imaging. Radiology 276:536–544.
17. Zhang, L. L., J. X. Li, G. Q. Zhou, L. L. Tang, J. Ma, A. H. Lin, et al. 2017. Influence of cervical node necrosis of different grades on the prognosis of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. J Cancer 8:959–966.
18. Wan, X. B., L. Wei, H. Li, M. Dong, Q. Lin, and X. K. Ma. 2013. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. Eur. J. Cancer 49:2356–2364.
19. Zhou, G. Q., L. L. Tang, Y. P. Mao, L. Chen, W. F. Li, Y. Sun, et al. 2012. Baseline serum lactate dehydrogenase levels for patients treated with intensity- modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. Int. J. Radiat. Oncol. Biol. Phys. 82:e359–e365.
20. Jonathan, R. A., K. I. Wijffels, W. Peeters, P. C. de Wilde, H. A. Marres, M. A. Merkx, et al. 2006. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother. Oncol. 79:288–297.
21. Ljungkvist, A. S., J. Bussink, P. F. Rijken, J. H. Kaanders, and A. J. van der Kogel. 2002. Denekamp J Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 54:215–228.
22. Edge, S. B., and C. C. Compton. 2010. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17:1471–1474.
23. Zhang, L. L., Y. P. Mao, G. Q. Zhou, L. L. Tang, Z. Y. Qi, L. Lin, et al. 2015. The evolution of and risk factors for neck muscle atrophy and weakness in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a retrospective study in an endemic area. Medicine (Baltimore). 94:e1294.
24. U.S. Department of health and human services. National cancer institute: Cancer therapy evaluation program. Common terminology criteria for adverse events, version 4.03 http://evs.Nci.Nih.Gov/ftp1/ctcae/ctcae_4.03_2010-0614_quickreference_5x7.Pdf. 2010 23
25. Experts committee on cancer-related anemia, Chinese Society of Clinical Oncology (CSCO). 2012. Clinical practice guidelines on cancer-related anemia (2012–2013 edition). Chin. Clin. Oncol. 1:18. https://doi.org/10.3978/j.issn.2304-3865.2012.10.01
26. Zenda, S., S. Hironaka, N. Boku, K. Yamazaki, H. Yasui, and A. Fukutomi, et al. 2008. Impact of Hemoglob in level on survival in definitive chemoradiotherapy for T4/M1lymph node esophageal cancer. Dis. Esophagus 21:195–200.Epub2008/04/24.https://doi.org/10.1111/j.1442-2050.2007.00750.xpmid:18430098.
27. Grogan, M., G. M. Thomas, I. Melamed, F. L. Wong, R. G. Pearcey, P. K. Joseph, et al. 1999. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.Cancer 86:1528–1536.Epub 1999.PMID:10526282.
28. Munstedt, K., M. Volzing, and R. VonGeorgi. 2004. Hemoglob in levels during radiation therapy and their influence on local control and survival of patients with endometrial carcinoma. Oncol. Rep. 11:711–717. Epub2004/02/10.PMID:14767527
29. Lin, Y. C., S. W. Chen, T. C. Hsieh, K. Y. Yen, S. N. Yang, Y. C. Wang, et al. 2015. Risk stratification of metastatic neck nodes by CT and FET in patients with head and neck cancer receiving definitive radiotherapy. J. Nucl. Med. 56:183–189.
30. Munck, J. N., E. Cvitkovic, J. D. Piekarski, E. Benhamou, G. Recondo, M. Bachouchi, et al. 1991. Computed tomography of metastatic lymph nodes as a treatment-related prognostic factor in advanced head-and-neck cancer. J. Natl. Cancer Inst. 83:569–575.
31. Grabenbauer, G. G., H. Steininger, M. Meyer, R. Fietkau, T. Brunner, P. Heinkelmann, et al. 1998. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head-and-neck cancer. Radiother. Oncol. 47:175–183.